Ipsen S.A.
IPSEY | OTC
$44.46
$0.00 (0.00%)
Nov 2, 2026, 10:15 AM ET · Market open
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
66.6
+11.6 ptsFundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #82/1028 (Top 8%)
Key Statistics
Market Data
Market Cap $58.79B
1D Range
43.89 44.46
52W Range
34.34 50.70
Valuation (TTM)
PE 6.17
PB 10.93
EV/EBITDA 26.02
Valuation (NTM)
Forward PE 46.93
Forward PEG 1.10
Price Target N/A
Cash Flow
FCF Yield 2.3%
SBC Adj. FCF Yield 2.3%
SBC Impact N/A
Margins
Gross Margin 67.5%
Operating Margin 30.1%
FCF Margin 30.3%
Growth (CAGR)
Revenue 3Y | 5Y 14.3% |
20.8%
Dil EPS 3Y | 5Y -16.1% |
17.1%
FCF 3Y | 5Y 35.3% |
37.5%
Returns
ROA 6.9%
ROE 11.3%
ROIC 14.9%
Financial Health
Net Cash
€1.08B ($1.24B)
Current Ratio 1.97
Interest Coverage 29.52
Dividends
Div Yield 1.03%
Payout Ratio 7.5%
FCF Payout Ratio 10.8%
Loading financial charts...
Profile
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the trea...
Latest News
11 days ago · seekingalpha.com
Ipsen S.A. (IPSEY) Q2 2026 Sales/Trading Call TranscriptIpsen S.A. (IPSEY) Q2 2026 Sales/Trading Call Transcript
3 months ago · seekingalpha.com
Ipsen S.A. (IPSEY) Q2 2026 Earnings Call TranscriptIpsen S.A. (IPSEY) Q2 2026 Earnings Call Transcript
Add to Watchlist
Select watchlists to add or remove IPSEY